ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 306107 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 306107; 2) Community: the network communities that were significantly associated with the response to NSC 306107; 3) Molecule: the relationships between components within communities and NSC 306107; 4) MDR: the compounds that were significantly associated with the NSC 306107.

NSC Compound Enrichment Correlation
NSC 708441 3-Iodoacetamido-benzoylurea 0.0220292715546634 -0.13801569
NSC 711014 Null 0.0220292715546634 -0.0885625
NSC 722779 dabequine 0.0220292715546634 -0.084279018
NSC 723741 Diethyl N-[4-[(3-phenyl-5,7-diaminoquinoxalin-2-yl)hydroxy]benzoyl]- L-glutamate 0.0220292715546634 -0.1188772
NSC 724771 Null 0.0220292715546634 -0.17663408
NSC 724794 5-Benzyl-9-hydroxy-5H-indeno[1,2-b]indol-10-one 0.0220292715546634 0.10928984
NSC 726718 3-(Benzothiazol-6-ylamino)-7-chloro-8-methyl-1,1,-dioxo-4H-1 ,5,2-benzodithiazepin-4-ylideneacetic acid 0.0220292715546634 -0.0048683083
NSC 727012 (2S,3S)-3,4-Epoxy-2-(3-methoxy-5-methyl-1-naphthoyloxy)-3-methylbutanamide 0.0220292715546634 -0.19055597
NSC 727985 NSC 708781 incorporated in micelles, 0.55% (w/w) of drug 0.0220292715546634 0.1067816
NSC 731399 2-Benzylthio-4-chloro-5-methyl-N-(2,3-dihydro-1H-benzimidazo l-2-yl)benzenesulfonamide 0.0220292715546634 -0.040040921
Total:120  Current:66    [First] [Prev] [Next] [Last]